221 related articles for article (PubMed ID: 23735826)
21. Antitumour polycyclic acridines. Part 4. Physico-chemical studies on the interactions between DNA and novel tetracyclic acridine derivatives.
Giménez-Arnau E; Missailidis S; Stevens MF
Anticancer Drug Des; 1998 Jul; 13(5):431-51. PubMed ID: 9702209
[TBL] [Abstract][Full Text] [Related]
22. Isoquino[4,5-bc]acridines: design, synthesis and evaluation of DNA binding, anti-tumor and DNA photo-damaging ability.
Yang P; Yang Q; Qian X; Tong L; Li X
J Photochem Photobiol B; 2006 Sep; 84(3):221-6. PubMed ID: 16714120
[TBL] [Abstract][Full Text] [Related]
23. Design, synthesis, and biological properties of new bis(acridine-4-carboxamides) as anticancer agents.
Antonini I; Polucci P; Magnano A; Gatto B; Palumbo M; Menta E; Pescalli N; Martelli S
J Med Chem; 2003 Jul; 46(14):3109-15. PubMed ID: 12825949
[TBL] [Abstract][Full Text] [Related]
24. A Review on Acridines as Antiproliferative Agents.
Baliwada A; Rajagopal K; Varakumar P; Raman K; Byran G
Mini Rev Med Chem; 2022; 22(21):2769-2798. PubMed ID: 35546777
[TBL] [Abstract][Full Text] [Related]
25. Synthesis and cytotoxic activity of new acridine-thiazolidine derivatives.
Barros FW; Silva TG; da Rocha Pitta MG; Bezerra DP; Costa-Lotufo LV; de Moraes MO; Pessoa C; de Moura MA; de Abreu FC; de Lima Mdo C; Galdino SL; Pitta Ida R; Goulart MO
Bioorg Med Chem; 2012 Jun; 20(11):3533-9. PubMed ID: 22546208
[TBL] [Abstract][Full Text] [Related]
26. Novel 3,9-Disubstituted Acridines with Strong Inhibition Activity against Topoisomerase I: Synthesis, Biological Evaluation and Molecular Docking Study.
Krochtová K; Halečková A; Janovec L; Blizniaková M; Kušnírová K; Kožurková M
Molecules; 2023 Jan; 28(3):. PubMed ID: 36770975
[TBL] [Abstract][Full Text] [Related]
27. Synthesis and antitumor activity of 5-(9-acridinylamino)anisidine derivatives.
Bacherikov VA; Chang JY; Lin YW; Chen CH; Pan WY; Dong H; Lee RZ; Chou TC; Su TL
Bioorg Med Chem; 2005 Dec; 13(23):6513-20. PubMed ID: 16140018
[TBL] [Abstract][Full Text] [Related]
28. Synthesis, DNA-binding and antiproliferative properties of acridine and 5-methylacridine derivatives.
Ferreira R; Aviñó A; Mazzini S; Eritja R
Molecules; 2012 Jun; 17(6):7067-82. PubMed ID: 22683895
[TBL] [Abstract][Full Text] [Related]
29. Quantitative analysis of structure-activity relationship in the acridine series. Part 2: Antitumor 9-thiadiazolo-acridine derivatives.
Mrozek A; Karolak-Wojciechowska J; Amiel P; Barbe J
Acta Pol Pharm; 2000; 57(6):425-30. PubMed ID: 11243248
[TBL] [Abstract][Full Text] [Related]
30. Induction of DNA fragmentation in human myelogenous leukaemic cell lines by phenothiazine-related compounds.
Sakagami H; Takahashi H; Yoshida H; Yamamura M; Fukuchi K; Gomi K; Motohashi N; Takeda M
Anticancer Res; 1995; 15(6B):2533-40. PubMed ID: 8669819
[TBL] [Abstract][Full Text] [Related]
31. 4-Hydroxymethyl-3-aminoacridine derivatives as a new family of anticancer agents.
Charmantray F; Demeunynck M; Carrez D; Croisy A; Lansiaux A; Bailly C; Colson P
J Med Chem; 2003 Mar; 46(6):967-77. PubMed ID: 12620073
[TBL] [Abstract][Full Text] [Related]
32. Linker length in podophyllotoxin-acridine conjugates determines potency in vivo and in vitro as well as specificity against MDR cell lines.
Rothenborg-Jensen L; Hansen HF; Wessel I; Nitiss JL; Schmidt G; Jensen PB; Sehested M; Jensen LH
Anticancer Drug Des; 2001 Dec; 16(6):305-15. PubMed ID: 12375883
[TBL] [Abstract][Full Text] [Related]
33. Crystal structure of the topoisomerase II poison 9-amino-[N-(2-dimethylamino)ethyl]acridine-4-carboxamide bound to the DNA hexanucleotide d(CGTACG)2.
Adams A; Guss JM; Collyer CA; Denny WA; Wakelin LP
Biochemistry; 1999 Jul; 38(29):9221-33. PubMed ID: 10413496
[TBL] [Abstract][Full Text] [Related]
34. Interest of acridine derivatives in the anticancer chemotherapy.
Demeunynck M; Charmantray F; Martelli A
Curr Pharm Des; 2001 Nov; 7(17):1703-24. PubMed ID: 11562307
[TBL] [Abstract][Full Text] [Related]
35. Antitumor polycyclic acridines. Part 16. Triplex DNA as a target for DNA-binding polycyclic acridine derivatives.
Missailidis S; Modi C; Trapani V; Laughton CA; Stevens MF
Oncol Res; 2005; 15(2):95-105. PubMed ID: 16119007
[TBL] [Abstract][Full Text] [Related]
36. New spiro-acridines: DNA interaction, antiproliferative activity and inhibition of human DNA topoisomerases.
Almeida SM; Lafayette EA; Silva WL; Lima Serafim V; Menezes TM; Neves JL; Ruiz AL; Carvalho JE; Moura RO; Beltrão EI; Carvalho Júnior LB; Lima MD
Int J Biol Macromol; 2016 Nov; 92():467-475. PubMed ID: 27435006
[TBL] [Abstract][Full Text] [Related]
37. Highly cytotoxic benzo[c]pyrido[2,3,4-kl]acridines.
Chackal S; Facompré M; Houssin R; Goossens JF; Pommery N; Hénichart JP; Bailly C
Bioorg Med Chem Lett; 2003 Mar; 13(5):943-6. PubMed ID: 12617926
[TBL] [Abstract][Full Text] [Related]
38. A new class of naphthalimide-based antitumor agents that inhibit topoisomerase II and induce lysosomal membrane permeabilization and apoptosis.
Chen Z; Liang X; Zhang H; Xie H; Liu J; Xu Y; Zhu W; Wang Y; Wang X; Tan S; Kuang D; Qian X
J Med Chem; 2010 Mar; 53(6):2589-600. PubMed ID: 20170164
[TBL] [Abstract][Full Text] [Related]
39. Acridine derivatives: a patent review (2009 - 2010).
Kaur J; Singh P
Expert Opin Ther Pat; 2011 Apr; 21(4):437-54. PubMed ID: 21323399
[TBL] [Abstract][Full Text] [Related]
40. 2,3-Dihydro-1H,7H-pyrimido[5,6,1-de]acridine-1,3,7-trione derivatives, a class of cytotoxic agents active on multidrug-resistant cell lines: synthesis, biological evaluation, and structure-activity relationships.
Antonini I; Polucci P; Kelland LR; Menta E; Pescalli N; Martelli S
J Med Chem; 1999 Jul; 42(14):2535-41. PubMed ID: 10411474
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
